204 related articles for article (PubMed ID: 23587910)
1. The hMLH1 promoter polymorphisms and cancer susceptibility in Asian populations: a meta-analysis.
He Y; Xu X; Chen H; Wang J; Xiong W; Xu Y; Liu J
Gene; 2013 Jul; 523(2):199-204. PubMed ID: 23587910
[TBL] [Abstract][Full Text] [Related]
2. Relevance of hMLH1 -93G>A, 655A>G and 1151T>A polymorphisms with colorectal cancer susceptibility: a meta-analysis based on 38 case-control studies.
Zare M; Jafari-Nedooshan J; Jafari M; Neamatzadeh H; Abolbaghaei SM; Foroughi E; Nasiri R; Zare-Shehneh M
Rev Assoc Med Bras (1992); 2018 Oct; 64(10):942-951. PubMed ID: 30517243
[TBL] [Abstract][Full Text] [Related]
3. The hMLH1 -93G>A Polymorphism and Risk of Ovarian Cancer in the Chinese Population.
Niu L; Li S; Liang H; Li H
PLoS One; 2015; 10(8):e0135822. PubMed ID: 26275295
[TBL] [Abstract][Full Text] [Related]
4. [Study on genetic polymorphism of human mismatch repair gene hMLH1 and susceptibility of papillary thyroid carcinoma in Chinese Han people].
Shi WP; Bian JC; Jiang F; Ni HX; Zhu QX; Tang HW; Shen Q; Wu Y
Zhonghua Yu Fang Yi Xue Za Zhi; 2010 Mar; 44(3):235-41. PubMed ID: 20450746
[TBL] [Abstract][Full Text] [Related]
5. The prognostic significance of polymorphisms in hMLH1/hMSH2 for colorectal cancer.
Wang Y; Li G; Hu F; Bi H; Wu Z; Zhao X; Li Y; Li S; Li D; Cui B; Dong X; Zhao Y
Med Oncol; 2014 Jun; 31(6):975. PubMed ID: 24793746
[TBL] [Abstract][Full Text] [Related]
6. -93G-->A polymorphism of hMLH1 and risk of primary lung cancer.
Park SH; Lee GY; Jeon HS; Lee SJ; Kim KM; Jang SS; Kim CH; Lee WK; Kam S; Park RW; Kim IS; Jung TH; Park JY
Int J Cancer; 2004 Nov; 112(4):678-82. PubMed ID: 15382050
[TBL] [Abstract][Full Text] [Related]
7. Association between MLH1 -93G>a polymorphism and risk of colorectal cancer.
Wang T; Liu Y; Sima L; Shi L; Wang Z; Ni C; Zhang Z; Wang M
PLoS One; 2012; 7(11):e50449. PubMed ID: 23226285
[TBL] [Abstract][Full Text] [Related]
8. Single nucleotide polymorphism in hMLH1 promoter and risk of tobacco-related oral carcinoma in high-risk Asian Indians.
Jha R; Gaur P; Sharma SC; Das SN
Gene; 2013 Sep; 526(2):223-7. PubMed ID: 23727610
[TBL] [Abstract][Full Text] [Related]
9. [Study on the relationship between genetic polymorphism Val384Asp in hMLH1 gene and the risk of four different carcinomas].
Zhang XM; Li JT; Zhu M; Wu XL; Gao P; Zhou P; Wang YP
Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Nov; 25(11):978-81. PubMed ID: 15769334
[TBL] [Abstract][Full Text] [Related]
10. MLH1 polymorphisms and cancer risk: a meta-analysis based on 33 case-control studies.
Xu JL; Yin ZQ; Huang MD; Wang XF; Gao W; Liu LX; Wang RS; Huang PW; Yin YM; Liu P; Shu YQ
Asian Pac J Cancer Prev; 2012; 13(3):901-7. PubMed ID: 22631669
[TBL] [Abstract][Full Text] [Related]
11. A polymorphism in the hMLH1 gene (-93G-->A) associated with lung cancer susceptibility and prognosis.
Shih CM; Chen CY; Lee IH; Kao WT; Wang YC
Int J Mol Med; 2010 Jan; 25(1):165-70. PubMed ID: 19956916
[TBL] [Abstract][Full Text] [Related]
12. Mismatch repair polymorphisms and colorectal polyps: hMLH1-93G>A variant modifies risk associated with smoking.
Yu JH; Bigler J; Whitton J; Potter JD; Ulrich CM
Am J Gastroenterol; 2006 Jun; 101(6):1313-9. PubMed ID: 16771955
[TBL] [Abstract][Full Text] [Related]
13. MLH1 -93G>A promoter polymorphism and the risk of microsatellite-unstable colorectal cancer.
Raptis S; Mrkonjic M; Green RC; Pethe VV; Monga N; Chan YM; Daftary D; Dicks E; Younghusband BH; Parfrey PS; Gallinger SS; McLaughlin JR; Knight JA; Bapat B
J Natl Cancer Inst; 2007 Mar; 99(6):463-74. PubMed ID: 17374836
[TBL] [Abstract][Full Text] [Related]
14. Association between polymorphism of interleukin-1 beta and interleukin-1 receptor antagonist gene and asthma risk: a meta-analysis.
He Y; Peng S; Xiong W; Xu Y; Liu J
ScientificWorldJournal; 2015; 2015():685684. PubMed ID: 25821855
[TBL] [Abstract][Full Text] [Related]
15. Contribution of the MLH1 -93G>a promoter polymorphism in modulating susceptibility risk in Malaysian colorectal cancer patients.
Nizam ZM; Abdul Aziz AA; Kaur G; Abu Hassan MR; Mohd Sidek AS; Yeh LY; Mazuwin M; Ankathil R
Asian Pac J Cancer Prev; 2013; 14(2):619-24. PubMed ID: 23621208
[TBL] [Abstract][Full Text] [Related]
16. The hMLH1 -93G>A promoter polymorphism is associates with outcomes in oral squamous cell carcinoma patients.
Lin LH; Lin MW; Mar K; Lin CS; Ji DD; Lee WP; Lee HS; Cheng MF; Hsia KT
Ann Surg Oncol; 2014 Dec; 21(13):4270-7. PubMed ID: 25047469
[TBL] [Abstract][Full Text] [Related]
17. Meta-analysis of association studies of CYP1A1 genetic polymorphisms with digestive tract cancer susceptibility in Chinese.
Liu C; Jiang Z; Deng QX; Zhao YN
Asian Pac J Cancer Prev; 2014; 15(11):4689-95. PubMed ID: 24969905
[TBL] [Abstract][Full Text] [Related]
18. Polymorphisms in hMLH1 and risk of early-onset lung cancer in a southeast Chinese population.
An Y; Jin G; Wang H; Wang Y; Liu H; Li R; Wang H; Qian J; Sun W; Wang Y; Ma H; Miao R; Hu Z; Jin L; Wei Q; Shen H; Huang W; Lu D
Lung Cancer; 2008 Feb; 59(2):164-70. PubMed ID: 17870204
[TBL] [Abstract][Full Text] [Related]
19. Promoter methylation of human mutL homolog 1 and colorectal cancer risk: A meta-analysis.
Shi B; Chu J; Gao Q; Tian T
J Cancer Res Ther; 2018; 14(4):851-855. PubMed ID: 29970664
[TBL] [Abstract][Full Text] [Related]
20. The MLH1 2101C>A (Q701K) variant increases the risk of gastric cancer in Chinese males.
Zhi W; Xue B; Wang L; Xiao N; He Q; Wang Y; Fan Y
BMC Gastroenterol; 2011 Dec; 11():133. PubMed ID: 22136435
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
